Rankings
▼
Calendar
ZTS Q1 2022 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$54B
Q1 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$2.0B
+6.1% YoY
Gross Profit
$1.4B
69.3% margin
Operating Income
$789M
39.7% margin
Net Income
$595M
30.0% margin
EPS (Diluted)
$1.26
QoQ Revenue Growth
+1.0%
Cash Flow
Operating Cash Flow
$309M
Free Cash Flow
$194M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$13.9B
Total Liabilities
$9.2B
Stockholders' Equity
$4.7B
Cash & Equivalents
$3.1B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.0B
$1.9B
+6.1%
Gross Profit
$1.4B
$1.3B
+7.3%
Operating Income
$789M
$755M
+4.5%
Net Income
$595M
$559M
+6.4%
Revenue Segments
Dogs and Cats
$1.2B
62%
Cattle
$364M
19%
Swine
$154M
8%
Poultry
$124M
6%
Horses
$64M
3%
Fish
$44M
2%
Geographic Segments
United States Segment
$1.0B
52%
International Segment
$948M
48%
← FY 2022
All Quarters
Q2 2022 →